Massey scientists may have found a new way to halt lung cancer growth
The gene p53 functions normally as a cancer suppressor, but mutated versions of the gene have been implicated in the development and growth of nearly half of all human cancers. Now, for the first time, scientists at VCU Massey Cancer Center have uncovered a mechanism that makes lung cancer cells dependent on mutated versions of the gene, opening the potential for new, more effective treatments.
Massey now offering HIPEC for advanced abdominal cancers
VCU Massey Cancer Center recently became the only cancer care provider in Richmond and one of only a handful in the state to offer heated intraperitoneal chemotherapy (HIPEC), a complex procedure used to treat advanced abdominal cancers.
Second opinions led to improved care and a clinical trial
Richmonder Bindu Panapalli’s experience with ovarian cancer has been difficult, but it’s hard to tell due to her cheerful disposition and contagious laugh. She recently finished treatments for ovarian cancer, and is now participating in a clinical trial studying the effects of diet and exercise on ovarian cancer recurrence.
Tips and inspiration for cancer survivorship
At VCU Massey Cancer Center, we believe that cancer survivorship begins at the point of diagnosis. In honor of National Cancer Survivors Month, we're sharing advice and goals for survivorship care for those who may be nearing the end of their treatments and are in remission. And to help inspire others on the various points along the survivorship spectrum, we included testimony from some of our current and former patients.
Massey researcher studies the effect of lipids on the development of cancer and other diseases
Massey cancer researcher Binks Wattenberg, Ph.D., studies the role that biological molecules play in the development of cancer and other malignancies in hopes of developing tools to potentially control and inhibit growth at the cellular level for a variety of diseases. Wattenberg joined VCU Massey Cancer Center as a member of the Cancer Cell Signaling research program in 2016 and is an associate professor in biochemistry and molecular biology at the VCU School of Medicine.